Moodle
You are not logged in. (Login)
Skip Check this out...
Show or hide block

Check this out...

Welcome to E-Menai

actos aciphex aciphex nasacort ambien Securities and Exchange Commission. In randomized clinical trials, Cambia was shown to be effective not only in migraine pain, but also in treating photophobia (sensitivity to light), phonophobia (sensitivity to sound), and nausea commonly associated with migraine attacks. About Migraine Migraine headaches affect an estimated 30 million people in the United States and disproportionately affect women 3 to 1.

.


NewsA Level

(KPA), a privately-held specialty pharmaceutical company headquartered in Montgomery, AL, announced today that the U. KPA and APR are currently in the final stages of negotiations with a marketing partner and expect Cambia to launch in 4th quarter 2009. About Migraine Migraine headaches affect an estimated 30 million people in the United States and disproportionately affect women 3 to 1. The Complete Response Letter raises issues regarding the potential abuse deterrent benefits of Acurox. disclaim any intent or obligation to update these forward-looking statements, and claim the protection of the Safe Harbor for forward-looking statements contained in the Act.S..